Northwest Biotherapeutics (NASDAQ:NWBO) is a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, today refuted false and misleading claims by Adam Feuerstein in an article posted Thursday, March 27, after NW Bio’s public presentation of significant positive news about all of the Company’s programs. Northwest Biotherapeutics, Inc (NASDAQ:NWBO) shares after opening at $7.29 moved to $7.45 on last trade day and at the end of the day closed at $7.18. Company price to sales ratio in past twelve months was calculated as 230.25 and price to cash ratio as 34.23. Northwest Biotherapeutics, Inc (NASDAQ:NWBO) showed a negative weekly performance of -3.88%.
Aegerion Pharmaceuticals (NASDAQ:AEGR) had its target price trimmed by Jefferies Group to $80.00. The firm currently has a buy rating on the stock. Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) shares fell 2.79% in last trading session and ended the day on $44.87. AEGR return on equity ratio is recorded as -53.80% and its return on assets is -45.10%. Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) yearly performance is 11.23%.
Celldex Therapeutics, Inc. (NASDAQ:CLDX) reported business and financial highlights for the fourth quarter and year ended December 31, 2013 and outlined the Company’s major clinical development goals for 2014. Celldex Therapeutics, Inc. (NASDAQ:CLDX) shares moved down -8.92% in last trading session and was closed at $16.95 while trading in range of $16.86 – $18.97 – Celldex Therapeutics, Inc. (NASDAQ:CLDX) year to date (YTD) performance is -29.99%.
Geron Corporation (NASDAQ:GERN) issued its quarterly earnings data on Thursday. The company reported ($0.07) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.06) by $0.01, AnalystRatings.Net reports. Geron Corporation (NASDAQ:GERN) weekly performance is -8.60%. On last trading day company shares ended up $2.02. Geron Corporation (NASDAQ:GERN) distance from 50-day simple moving average (SMA50) is -51.80%. Analysts mean target price for the company is $2.00.